Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Phillips Edison & Company Declares Quarterly Dividends; Increases Monthly Dividend Distribution by 5.7%

(NASDAQ:PECO) CINCINNATI, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of high-qua...

What short‑term price reaction and volatility can traders expect following the announcement? Is the increased dividend sustainable given PECO's current cash flow generation and debt profile? How will the 5.7% dividend increase affect PECO's dividend yield and valuation multiples relative to its peers?
Symbol: PECO
Dividends
14 days ago
Read more globenewswire

Nexxen Announces August 2025 Share Repurchase Program Summary

(NASDAQ:NEXN) NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep exper...

How does Nexxen's buyback activity compare to its peers in the advertising technology sector and what could that indicate about competitive positioning? What is the remaining cash reserve after the repurchase and does the company have sufficient funds for future buybacks or dividends? How will the August 2025 share repurchase affect Nexxen's earnings per share and valuation metrics?
Symbol: NEXN
Buybacks
14 days ago
Read more globenewswire

Codere Online Announces Chief Financial Officer Transition to New Role

(NASDAQ:CDRO) Luxembourg, Grand Duchy of Luxembourg, September 2, 2025 – (GLOBE NEWSWIRE) Codere Online (Nasdaq: CDRO / CDROW, the “Company”), a leading online gaming operator in Spain and Latin Am...

Could this leadership change trigger any strategic or operational adjustments that might impact the company's valuation or market position? Who is the identified successor or interim CFO, and what relevant experience do they have in the online gaming industry? What effect will the CFO's departure have on Codere Online's upcoming financial guidance and earnings forecasts?
Symbol: CDRO
Management
14 days ago
Read more globenewswire

BPC Instruments expands into the textile sector - receives order from a global materials company

(BPC) LUND, Sweden, Sept. 2, 2025 /PRNewswire/ -- BPC Instruments AB (publ) is extending the industrial application of its BPC® Blue platform into the textiles & apparel sector, broadening the comp...

How might this expansion influence BPC's competitive positioning and valuation relative to peers in sustainable materials testing? What is the expected timeline and scale of the order from the global materials company, and how does it compare to BPC's existing contracts? How will the entry into the textile & apparel sector affect BPC's revenue growth and profit margins?
Symbol: BPC
Expansion
14 days ago
Read more prnewswire

Hammond Power Solutions Provides Update on U.S. Tariff Changes

(NYSE:HPS) GUELPH, Ontario, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Hammond Power Solutions Inc. (“HPS” or the “Company”) (TSX: HPS.A) has determined that the recently expanded U.S. tariffs on steel a...

How does HPS's exposure to these tariffs compare with its peers in the power solutions sector, and what mitigation strategies is the company implementing? What is the expected impact of the tariffs on HPS's revenue forecasts and stock valuation in the short to medium term? How will the expanded U.S. tariffs on steel and aluminum affect HPS's profit margins and cost structure?
Symbol: HPS
Tariffs
14 days ago
Read more globenewswire

Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million

(NASDAQ:RPRX) NEW YORK and WALTHAM, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Zenas BioPharma, Inc. (Nasdaq: ZBIO) today announced that Royalty Pharma will p...

How does this royalty arrangement compare to similar financing structures in the biotech sector and what are the potential dilution or upside risks for investors? What impact will the obexelimab funding agreement have on Zenas BioPharma’s valuation and share price volatility? How will the $300 million royalty financing deal affect Royalty Pharma’s cash flow and earnings outlook?
Symbol: RPRX
Funding
14 days ago
Read more globenewswire